Status:
COMPLETED
Does Shared Decision-Making Improve Adherence in Asthma
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Lung Diseases
Asthma
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
To evaluate a model of shared decision-making for asthma treatment, appropriate to the needs of African American, Latino, Chinese, and other Asian and low income Caucasian patients to adherence to ast...
Detailed Description
BACKGROUND: Asthma is a chronic inflammatory disorder of the airways. Despite major advances in understanding of its pathophysiology and management, asthma outcomes have not shown parallel improvemen...
Eligibility Criteria
Inclusion
- Kaiser Health Care Program member for more than 1 yr.
- Site: Portland, OR, Honolulu, HI, San Francisco, Oakland, or Richmond, CA.
- Confirmed diagnosis of persistent asthma with currently prescribed medications; no daily or alternate daily oral corticosteroid
- Evidence of poorly controlled asthma: score of \>=1 on ATAQ asthma control questionnaire1 and either overuse of rescue medication vs. controller medications and/or recent emergency visit or hospitalization for asthma
- COPD not the primary lung disease diagnosis
- Regular use of Inhaled Corticosteroid (ICS) and current/ex-smokers: \>= 8% increase in FEV1 post-bronchodilator; if no routine ICS use +/- smoking HX: \>= 12% increase required; non-smokers using ICS regularly not required to reverse
Exclusion
Key Trial Info
Start Date :
September 1 2001
Trial Type :
INTERVENTIONAL
End Date :
August 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00217945
Start Date
September 1 2001
End Date
August 1 2007
Last Update
July 29 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.